Biocept (BIOC)
Biocept's (BIOC) CEO Michael Nall on Q1 2017 Results - Earnings Call Transcript
May 13, 2017 | Price: Free! | Source: Seeking Alpha
Biocept's (BIOC) CEO Michael Nauman on Q1 2017 Results - Earnings Call Transcript
March 7, 2017 | Price: Free! | Source: Seeking Alpha
Recent filings
Biocept director was just granted 15,000 options - June 2, 2017
Biocept director was just granted 15,000 options - June 2, 2017
Biocept director was just granted 15,000 options - June 2, 2017
Biocept director was just granted 15,000 options - June 2, 2017
Biocept's CEO & President just picked up 50,000 shares - June 2, 2017
Biocept Just Filed Its Quarterly Report: 10. Net Loss per Co... - May 15, 2017
Securities to be offered to employees in employee benefit plans - May 15, 2017
Biocept Reports First Quarter 2017 Financial Results - May 11, 2017
Biocept: With Respect To Restricted Awards, The Restricted Period Sha - May 5, 2017
Notice of Exempt Offering of Securities, item 06b - April 10, 2017
Biocept director was just granted 4,166 options - April 3, 2017
Biocept director was just granted 4,166 options - April 3, 2017
Biocept director was just granted 4,166 options - April 3, 2017
Biocept director was just granted 4,166 options - April 3, 2017
Biocept director was just granted 4,166 options - April 3, 2017
Biocept director was just granted 4,166 options - April 3, 2017
Biocept director was just granted 4,166 options - April 3, 2017
Biocept releases salary data. CEO sees compensation fall -14% - March 30, 2017
Biocept Announces Pricing Of $9.3 Million Financing - March 30, 2017
Biocept director just picked up 5,667 shares - March 29, 2017
Biocept just filed a prospectus, suggesting it plans to soon issue some securities - March 29, 2017
Biocept Just Filed Its Annual Report: 12. Net Loss per Co... - March 28, 2017
Shareholder Director - March 23, 2017
CFO of Biocept was just granted 16,383 options - March 22, 2017
Biocept's CEO & President was just granted 16,333 options - March 22, 2017
Biocept Reports Fourth Quarter And Full Year 2016 Financial Results - March 7, 2017
Biocept's Sr VP Comm. Operations was just granted 50,000 options - Feb. 28, 2017
Biocept's Sr VP Comm. Operations just declared owning 2,900 shares of Biocept - Feb. 16, 2017
Biocept’S Ceo Issues Letter To Stockholders - Feb. 9, 2017
Bin Li just provided an update on activist position in Biocept - Jan. 27, 2017
Major owner of Biocept just disposed of 1,681,000 shares - Jan. 26, 2017
On November - Jan. 25, 2017
Sabby Healthcare Master Fund, Ltd. just provided an update on share ownership of Biocept - Jan. 11, 2017
Notice of Delisting or - Dec. 2, 2016
Biocept Just Filed Its Quarterly Report: 10. Net Loss per Co... - Nov. 10, 2016
Biocept Reports 2016 Third Quarter Financial Results - Nov. 9, 2016
Termination of a Material Definitive - Nov. 4, 2016
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or - Oct. 28, 2016
Major owner of Biocept just declared owning 1,681,000 shares of Biocept - Oct. 24, 2016
Daniel V. Tierney just provided an update on share ownership of Biocept - Oct. 24, 2016
Biocept director just picked up 20,000 shares - Oct. 21, 2016
Biocept director just picked up 90,909 shares - Oct. 21, 2016
Biocept director just picked up 227,272 shares - Oct. 21, 2016
CFO of Biocept just picked up 36,363 shares - Oct. 21, 2016
Major owner of Biocept just picked up 227,272 shares - Oct. 21, 2016
Biocept director just picked up 13,636 shares - Oct. 21, 2016
Biocept's SR VP of R&D and CSO just picked up 45,000 shares - Oct. 21, 2016
Biocept director just picked up 4,545 shares - Oct. 21, 2016
Biocept director just picked up 50,000 shares - Oct. 21, 2016
Biocept's Sr VP & Sr Med Director just picked up 10,000 shares - Oct. 21, 2016
Biocept's CEO & President just picked up 36,363 shares - Oct. 21, 2016
Bin Li just provided an update on activist position in Biocept - Oct. 20, 2016
Sabby Healthcare Master Fund, Ltd. just provided an update on share ownership of Biocept - Oct. 17, 2016
Biocept just filed a prospectus, suggesting it plans to soon issue some securities - Oct. 14, 2016
Post-effective amendment adding exhibits to registration statement [Rule 462(d)] - Oct. 14, 2016
Biocept Just Received a Notice of Effectiveness - Oct. 13, 2016
General form for registration of securities under the Securities Act of 1933 - Oct. 6, 2016
General form for registration of securities under the Securities Act of 1933 - Sept. 29, 2016
Biocept: Risks Relating To Our Financial Condition And Capital Requirements - Sept. 29, 2016
Other definitive proxy statements - Aug. 31, 2016
General form for registration of securities under the Securities Act of 1933 - Aug. 12, 2016
Other preliminary proxy statements - Aug. 11, 2016
Biocept Just Filed Its Quarterly Report: 9. Net Loss per Com... - Aug. 5, 2016
Securities to be offered to employees in employee benefit plans - Aug. 5, 2016
Biocept Reports 2016 Second Quarter Financial Results - Aug. 2, 2016
CFO of Biocept just picked up 75,000 shares - Aug. 1, 2016
Departure of Directors or Certain - Aug. 1, 2016
CFO of Biocept just declared ownership of no shares of Biocept - July 27, 2016
Biocept Appoints Timothy C. Kennedy As Chief Financial Officer And Senior Vice President Of Operations - July 27, 2016
Biocept's SR VP of R&D and CSO just picked up 50,000 shares - July 7, 2016
Departure of Directors or Certain - July 7, 2016
Biocept's Sr VP & Sr Med Director just picked up 50,000 shares - July 7, 2016
Biocept's CEO & President just picked up 75,000 shares - July 7, 2016
Submission of Matters to a Vote of Security - June 29, 2016
Notice of Delisting or - June 17, 2016
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or - May 26, 2016
Biocept releases salary data. CEO sees compensation fall -29% - May 18, 2016
Biocept Just Filed Its Quarterly Report: 9. Net Loss per Com... - May 13, 2016
Biocept Reports 2016 First Quarter Financial Results - May 12, 2016
Biocept just filed a prospectus, suggesting it plans to soon issue some securities - May 10, 2016
Biocept Just Received a Notice of Effectiveness - May 10, 2016
Statement of acquisition of beneficial ownership by individuals - May 6, 2016
Biocept director just picked up 100,000 shares - May 5, 2016
Biocept director just picked up 50,000 shares - May 5, 2016
Major owner of Biocept just picked up 614,273 shares - May 5, 2016
Biocept director just picked up 25,000 shares - May 5, 2016
Major owner of Biocept just declared owning 14,012 shares of Biocept - May 5, 2016
Post-Effective amendments for registration statement - May 4, 2016
Prospectus [Rule 424(b)(5)] - April 29, 2016
Biocept just filed a prospectus, suggesting it plans to soon issue some securities - April 29, 2016
Biocept, Inc. Announces Pricing Of $5 Million Public Offering Of Common Stock And Warrants - April 29, 2016
Post-Effective amendments for registration statement - April 29, 2016
Biocept: Documents Incorporated By Reference TABLE OF CONTENTS Explanatory Note Part III Item 10 - April 25, 2016
Annual report [Section 13 and 15(d), not S-K Item 405] - March 10, 2016
Prospectus [Rule 424(b)(3)] - March 10, 2016
BioClinica: Biocept Reports 2015 Fourth Quarter And Full Year Financial Results - March 9, 2016
BioClinica's VP Commercial Operations was just granted 17,500 options - March 1, 2016
BioClinica's CEO & President just picked up 13,348 shares - March 1, 2016